Why is the Atomo (ASX:AT1) share price trending downwards?

The Atomo Diagnostics Limited (ASX: AT1) share price is down 16% since this time last month. What's been driving its share price lately?

| More on:
a doctor looking up at question marks

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Atomo Diagnostics Limited (ASX: AT1) share price is down 16% since this time last month. With no news from the company, what's been driving its share price lower lately?

At the time of writing, the Atomo share price is 24 cents, just 1 cent above its all-time lowest closing price.

Let's look at what's been going on with the company's share price over the last few months.

What does Atomo Diagnostics do?

Atomo Diagnostics is an Australian medical device company that supplies the global market with blood-based rapid diagnostic test (RDT) devices.

It aims to provide technology that simplifies and improves the accuracy of the blood testing process. 

The company offers products for both medical professionals and people who need to perform self-testing.

Recently, Atomo has secured the Therapeutic Good Administration's approval for its RDTs, one of which works to detect HIV and the other to detect COVID-19 immunity. 

What's been moving the Atomo Diagnostics share price lately?

The last time we heard from Atomo Diagnostics was when the company was removed from the All Ordinaries Index (ASX: XAO) on 12 March.

Prior to that, the company posted its quarterly earnings in late February. While many of its half-year metrics were positive, with a revenue increase of 389% and gross profit lifting by 278%, its share price dropped.

It's possible the drop in the company's share price is the result of its earnings before interest, tax, depreciation and amortisation (EBITDA) loss of around $2.12 million, although Atomo still held $24.69 million in cash and no debt.

It also announced a number of positive updates from its HIV and COVID-19 immunity RTDs between October and December 2020, but none since. 

Atomo share price snapshot

Atomo Diagnostics is still a relatively new company on the ASX. It was first floated this time last year.

The company's share price got off to a slow start. On the close of its first day on the ASX, its shares were trading at 39 cents apiece. Two trading days later, it reached its highest closing price so far, finishing the day at 54 cents.

It's been trending downwards ever since, having dropped 39.74% since its debut and 24.19% in 2021.

Atomo Diagnostics has a market capitalisation of around $95 million, with approximately 408 million shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 

More on Share Fallers

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Bapcor, Boss Energy, Macquarie, and Novonix shares are falling today

These shares are having a tough session on Thursday. But why?

Read more »

Stock market crash concept of young man screaming at laptop on the sofa.
Share Fallers

Guess which ASX 200 stock just crashed 31% on slumping sales

The $1.3 billion ASX 200 stock is getting hammered today.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why CBA, Inghams, Praemium, and Strike Energy shares are tumbling today

These shares are having a tough time on Tuesday. But why?

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Share Fallers

Why Brightstar, Eagers Automotive, Regis Resources, and Westpac shares are sinking

These shares are starting the week in the red. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why 29Metals, CAR Group, DroneShield, and Santana Minerals shares are falling today

These shares are missing out on the good times on Thursday. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Imricor, Imugene, Newmont, and Pepper Money shares are falling today

These shares are having a tough time on hump day. But why?

Read more »